The patient controlled injectors market was valued at US$ 2,969.47 million in 2019 and is projected to reach US$ 7,505.70 million by 2027; it is expected to grow at a CAGR of 12.4% during 2020–2027. The growth of the patient controlled injectors market is mainly attributed to the factors such as increasing prevalence of chronic diseases and rising patient compliance. However, lack of adoption in emerging countries is likely to restraint the growth of the market during the forecast years.
Patient-controlled injectors are expected to rise concurrently in the market owing to greater ease, safety, and comfort of the administration of injections, which is likely to gain significant popularity among patients. Additionally, the controlled release of the patient-controlled injectors helps the patient administer the drug by themselves and decide their dosage rate.
Besides, the patient-controlled injectors can be administered at home settings, and thus, there is an increase in demand for patient-controlled injectors.Patient-controlled injectors present a strong solution for higher dosing volumes in non-clinical settings.
Large volume of patient-controlled injectors are used for subcutaneous drug delivery at home care setting.Variants like these patient controlled self-administration devices are especially designed to administer highly viscous medications in large volumes.
As per the WHO, ~2 million healthcare workers experience percutaneous exposure to infectious diseases each year. It further reveals that 37.6% of Hepatitis B and 4.4% of HIV/AIDS infections in healthcare workers are due to needle stick injuries worldwide. Many manufacturers are now focusing on developing patient-controlled injectors to meet the unmet needs, which, in turn, is stimulating the growth of the market. The easy administration of these drugs plays a crucial role in improving the compliance to drug therapies among patients, which drives patient outcomes. Considering these factors, the preference for controlled injectors, such as self-dose and Tremfya, is increasing among patients and healthcare providers. Besides, this self-injector is considered safe and efficacious among patients. For instance, according to a clinical trial report of July 2019, Guselkumab administered using the one-press patient controlled injector was very efficacious and well-tolerated in moderate-to-severe psoriasis patients. The researchers concluded that one-press controlled injector was highly acceptable over conventional drug delivery. Thus, unlike other drug delivery routes, this innovative route of administration does not require rigorous sterile methods for administering drugs into the body. Therefore, increasing preference for patient-controlled injectors among patients and health care providers, due to growing awareness regarding its benefits, is driving the market growth.
The demand for patient controlled injectors increased during the pandemic.Factors such as increased patient population, shortage of healthcare resources, and ease of increased the adoption of injectors had positive impact on the market by certain extent.
However, implementation of physical distancing policies and total shut down of businesses in order to prevent the viral infection disrupted the supply chain operations, which caused a negative impact on the market growth.
Based on product, the patient controlled injectors market is segmented into electronic wearable injector, mechanical wearable injector, and infusion pumps. In 2019, the electronic wearable segment held the largest share of the market, whereas, the mechanical wearable injector segment is projected to register the highest CAGR in the market during the forecast period.
Based on application, the patient controlled injectors market is segmented into cancer treatment, auto-immune treatment, blood disorders treatment, and others. The cancer treatment segment held the largest share of the market in 2019 and is estimated to register the fastest growth during the forecast period.
Based on distribution channel, the patient controlled injectors market is segmented into hospital pharmacies, retail pharmacies, and mail order pharmacies. The hospital pharmacies segment held the largest share of the market in 2019 and is estimated to register the fastest growth during the forecast period.
The World Health Organization (WHO), Food and Drug Administration (FDA), NHS (National Health Service), and Centers for Disease Control and Prevention are among the major primary and secondary sources referred for preparing this report.
Our reports have been used by over 10K customers, including:
The Europe patient controlled injectors market is expected to reach US$ 2,051.31 million by 2027 from US$ 835.44 million in 2019; it is expected to grow at a CAGR of 12.0% from 2020 to 2027. The increasing prevalence of chronic diseases and limitations on conventional drug delivery system boost the growth of the market.However, the preference...
The gastroparesis market was valued at US$ 4,338.61 million in 2019 and is projected to reach US$ 6,025.11 million by 2027; it is expected to grow at a CAGR of 4.3% during 2020–2027. The growth of the market is mainly attributed to the increasing prevalence of diabetes and growing geriatric population. However, side effects of gastroparesis...
The North America patient controlled injectors market is expected to reach US$ 3,236.46 million by 2027 from US$ 1,261.43 million in 2019; it is expected to grow at a CAGR of 12.6% from 2020 to 2027. The increasing prevalence of chronic diseases and limitations on conventional drug delivery system boost the growth of the market.However,...
The Asia Pacific patient controlled injectors market is expected to reach US$ 1,637.74 million by 2027 from US$ 621.47 million in 2019; it is expected to grow at a CAGR of 12.9% from 2020 to 2027. The increasing prevalence of chronic diseases and limitations on conventional drug delivery system boost the growth of the market.However, the...
The anticoagulant reversal drugs market is expected to reach US$ 2,276.54 million in 2027 from US$ 922.55 million in in 2019; it is estimated to grow at a CAGR of 12.6% from 2020 to 2027.The growth of the anticoagulant reversal drugs market is mainly attributed to rising prevalence of atrial fibrillation (AFib) and stroke. However, the high...
The Cardiovascular drug market studied was anticipated to grow with a CAGR of nearly 3.8% during the forecast period. The major factors driving the growth of the market are the rising global prevalence of various coronary heart diseases such as stroke, cardiomyopathy causing a global burden of cardiac deaths and favorable reimbursement initiatives....
195 pages •
By Asia Market Information & Development Company
• Feb 2021
China’s demand for Hearing Aids has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
The adult diaper market was valued at USD 9,792.67 Million in 2020 and is projected to witness a CAGR of 8.90% during the forecast period (2021-2026). The ongoing COVID-19 pandemic has increased the awareness among the consumers for the usage of disposable hygiene products, including adult diapers as a precautionary measure, driven...
The dairy alternatives market is estimated to be valued at USD 22.6 billion in 2020 and is projected to reach USD 40.6 billion by 2026, recording a CAGR of 10.3 % in terms of value. The market is primarily driven by factors such as the growing vegan and flexitarian population across the world and increasing incidences of lactose-intolerant...
The global pink Himalayan salt market is projected to witness a CAGR of 3.39% during the forecast period (2020 - 2025). - Pink Himalayan salt is a premium-priced culinary salt, and a type of gourmet salt which comes from one of the largest rock-salt mining operations in the world, namely, the Khewra Salt Mine in the Punjab Region of...
Health Insurance Claims
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.